Related Experiment Video
Updated: Jul 6, 2026

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
Published on: August 14, 2019
Tamsulosin MR and OCAS (modified release and oral controlled absorption system): current therapeutic uses
Vinod H Nargund1, Alistair D R Grey
1St Bartholomew's Hospital, Department of Genito-Urinary Surgery, West Smithfield, London EC1A 7BE, UK. Vinod.nargund@bartsandthelondon.nhs.uk
Background:
Although tamsulosin is mainly used to treat lower urinary tract symptoms secondary to benign prostatic hyperplasia, with better understanding of functional anatomy and distribution of alpha(1) receptors, it is also indicated in other conditions of genito-urinary tract in both men and women.
Objective:
To detail the therapeutic use and clinical effects of tamsulosin.
Methods:
The scope of the review was related to tamsulosin and its therapeutic application in conditions of genitourinary tract. Publications were searched from Pubmed and Medline from 1975 to 2007 using the search words tamsulosin, lower urinary tract symptoms, alpha receptors and blockers.
Conclusions:
The management of benign prostatic hyperplasia was transurethral resection of prostate until simpler and alternative treatments were tried in the last two decades, particularly alpha(1) adrenoceptor-blocking agents. Tamsulosin is a potent, third-generation selective alpha(1A) adrenoceptor-blocking agent.
Related Concept Videos
Oral Drug Delivery Systems: Continuous-Release Systems
Modified-Release Drug Delivery Systems: Overview
Modified-Release Drug Delivery Systems: Bioavailability
Modified-Release Drug Delivery Systems: Drug Release Characteristics
Drug Delivery Systems: Different Types
Modified-Release Drug Delivery Systems: Classification